chartexchange

FTXH
First Trust Nasdaq Pharmaceuticals ETF
stockNASDAQETF

At CloseNov 18, 2026 3:59:46 PM EST
43.06USD-0.799%(-0.35)33,314
Pre-marketNov 18, 2026 8:33:30 AM EST
44.19USD+1.817%(+0.79)
After-hoursNov 18, 2026 4:13:30 PM EST
43.40USD+0.801%(+0.34)
Loading…
Loading…
HQ
USA
Previous Close
$43.40
Beta
0.51
52-Week High
$45.10 2026-11-05
52-Week Low
$31.42 2025-11-20
SMA 50
$42.23
SMA 200
$37.85
Avg. Vol 10D
397,173
Avg. Vol 30D
218,751
Avg. Vol 90D
556,595
Relative Vol
0.15
24.75M
4.3300%
5,625
Dec 24, 2020 · $0.064
FTXH Profile

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is designed to select pharmaceuticals stocks from the base index based on a ranking methodology of three price factors which aims to select companies that exhibit: strong growth through high average 3-, 6-, 9- and 12-month price return; value; and low expected volatility based on historical stock price fluctuation. It is non-diversified.

FTXH Performance
PeriodPriceDateChangeBeta
1W44.152026-11-12-2.47%0.397
1M41.592026-10-19+3.53%0.737
3M42.602026-08-19+1.08%0.652
6M33.902026-05-19+27.03%0.332
1Y31.612025-11-19+36.23%0.508
2Y27.132024-11-19+58.72%—
5Y26.492021-11-19+62.55%0.486
FTXH Stock Summary

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) stock price today is $43.06, and today's volume is 33,314. FTXH is down 0.787% today. The 30 day average volume is 218,751. FTXH market cap is $1.17B with 27.20M shares outstanding.